Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Hasibeder, H; Staab, HJ; Seibel, K; Heibel, B; Schmidle, G; März, W.
Clinical pharmacology of the hypocholesterolemic agent K 12.148 (lifibrol) in healthy volunteers.
Eur J Clin Pharmacol. 1991; 40 Suppl 1(1): S91-S94.
Doi: 10.1007/BF01409417
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
- März Winfried
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- K 12.148 (INN:lifibrol), a new cholesterol synthesis inhibitor, was studied in healthy volunteers to evaluate tolerance/safety, the effects on lipids, and pharmacokinetics. In a sequential block design the doses of 150, 300, 600, or 900 mg, given once daily in the morning for 14 consecutive days, were examined in 40 healthy young males (8 active drug and 2 placebo per group, randomized) under well-controlled conditions. Total and LDL cholesterol serum levels decreased significantly in the 300, 600, and 900 mg groups (-13.4%, -23.8%, -25.6%, and -14.7%, -33.3%, -34.8%, respectively). whereas no significant change was seen with placebo and 150 mg. The antiatherogenic index Apo A-I/B increased in a dose-dependent manner between 300 and 900 mg. Changes in HDL cholesterol and triglycerides were not statistically significant. The study compound was tolerated well, and safety laboratory parameters did not show any relevant alterations, K 12.148 might be a very effective drug for the treatment of hypercholesterolemia.
- Find related publications in this database (using NLM MeSH Indexing)
- Adolescent -
- Adult -
- Antilipemic Agents - pharmacokinetics
- Butanols - pharmacokinetics
- Dose-Response Relationship, Drug - pharmacokinetics
- Double-Blind Method - pharmacokinetics
- Humans - pharmacokinetics
- Hydroxybenzoic Acids - pharmacokinetics
- Male - pharmacokinetics
- Molecular Structure - pharmacokinetics
- Random Allocation - pharmacokinetics
- Reference Values - pharmacokinetics